Stock Taper
SCREENER COMPARE ANY 2 STOCKS
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
OTC
$0.52
▲ UP 2.78% (0.01)

KEY STATISTICS

Market Cap$6.64 M
52w High$17.20
52w Low$0.26
Dividend Yield—
Frequency—
P/E6.48
Volume5.72K
Shares Out.12.81M

COMPANY

LEADERSHIP

Laxminarayan Bhat
CHIEF EXECUTIVE
Laxminarayan Bhat

COMPENSATION 2026

Salary$450,000
Stock Awards$0
Incentive Plan Pay$157,500
All Other Comp.$0
Total$2,764,747

ABOUT

SECTOR
Healthcare
WENT PUBLIC
December 15, 2020
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
14

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.—
NOV
12
THU

SPLIT RECORD

DATETYPERATIO
2026-03-09Reverse1:20

PRICE

$0.52 ▲ UP 2.78% (+$0.01)
OVERLAYS
$0.50$0.51$0.529:30 AM10:24 AM11:17 AM12:11 PM1:05 PM1:58 PM2:52 PM0.52

About Reviva Pharmaceuticals Holdings, Inc.

https://www.revivapharma.com ↗

Reviva Pharmaceuticals is a clinical-stage biopharma developing next-generation therapeutics for CNS, respiratory, cardiovascular, metabolic, and inflammatory diseases, with lead candidate RP5063 in Phase III for schizophrenia.

INDUSTRY

Biotechnology

A PRODUCT REVIVA PHARMACEUTICALS HOLDINGS, INC. IS KNOWN FOR

Brilaroxazine (RP5063)
Brilaroxazine (RP5063)

Brilaroxazine, Reviva Pharmaceuticals' lead investigational drug, is a serotonin-dopamine modulator evaluated for schizophrenia and potential treatments for bipolar disorder, depression, ADHD, PAH, and IPF.

COMPETITORS

COMPETITOR
ATAI COMPARE
AXSM COMPARE
VNDA COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
11
LISTED HERE
1
RANKED BY POSITION SIZE
VTS.AX
0.00% · 59.6K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
100.00%
HOLDERS
65
TOP 12 OF 65 · RANKED BY POSITION SIZE
Vanguard Group Inc
3.2M sh · $892.13K
Armistice Capital, LLC
2.7M sh · $1.03M
Diadema Partners LP
2.5M sh · $924.05K
Millennium Management LLC
2.3M sh · $631.51K
Geode Capital Management, LLC
1.0M sh · $292.68K
Jane Street Group, LLC
894.7K sh · $249.64K
Highbridge Capital Management LLC
762.2K sh · $556.2K
Jpmorgan Chase & Co
762.2K sh · $556.2K
Susquehanna International Group, Llp
682.1K sh · $190.29K
Persistent Asset Partners Ltd
593.9K sh · $218.91K
Citadel Advisors LLC
554.6K sh · $154.74K
State Street Corp
383.2K sh · $106.91K

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book5
Overall Score3

INSIDER TRADES

★
OFFICER: CHIEF FINANCIAL OFFICER
Prabhu Narayan
Purchase · 40.9K shares
2026-03-18
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Bhat Laxminarayan
Purchase · 109.2K shares
2026-03-18
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Bhat Laxminarayan
Purchase · 40.9K shares
2026-03-18
★
DIRECTOR
Funtleyder Leslie D.
Purchase · 8.2K shares
2025-12-18

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 4
HOLD 2
SPECULATIVE BUY 1
7 GRADES IN THE LAST 12 MONTHS
Maxim Group HOLD Roth Capital BUY Alliance Global Partners BUY D. Boral Capital HOLD Chardan Capital BUY HC Wainwright & Co. BUY Benchmark SPECULATIVE BUY

SECTORS PEERS

PEERPRICE
PYPD$5.07COMPARE
ANVS$1.72COMPARE
CELU$1.58COMPARE
EVAX$3.01COMPARE
TVRD$1.82COMPARE
PDSB$0.21COMPARE
BTAI$0.18COMPARE
BCAB$1.74COMPARE